Abilita Bio is a biotechnology company developing technologies for the discovery and development of drugs.
Abilita Bio has raised $7.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
Abilita Bio's investors include Two Bear Capital.
Abilita Bio is headquartered in San Diego, United States.
Abilita Bio is a biotechnology company developing technologies for the discovery and development of drugs.
Abilita Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abilita Bio — Funding & Investors." VCBacked, February 21, 2023, https://www.vcbacked.co/company/abilita-bio. Accessed August 13, 2026.
VCBacked. (2023). Abilita Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/abilita-bio
{{cite web |title=Abilita Bio — Funding & Investors |url=https://www.vcbacked.co/company/abilita-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated